{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:24:17Z","timestamp":1785291857213,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Italian Ministry of Health","award":["Finalizzata no. 88"],"award-info":[{"award-number":["Finalizzata no. 88"]}]},{"name":"Italian Ministry of Health","award":["2004"],"award-info":[{"award-number":["2004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00394-017-1548-2","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T07:23:41Z","timestamp":1508484221000},"page":"2805-2817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Decreased diabetes risk over 9\u00a0year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)"],"prefix":"10.1007","volume":"57","author":[{"given":"Lucilla D.","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Galluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Spadoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Marco","family":"Piatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"1548_CR1","first-page":"173","volume":"10","author":"KC Portero McLellan","year":"2014","unstructured":"Portero McLellan KC (2014) Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther Clin Risk Manag 10:173\u2013188","journal-title":"Ther Clin Risk Manag"},{"key":"1548_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","volume":"24","author":"Diabetes Prevention Program (DPP) Research Group","year":"2007","unstructured":"Diabetes Prevention Program (DPP) Research Group (2007) The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 24:137\u2013144","journal-title":"Diabet Med"},{"key":"1548_CR3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2009.10.060","volume":"55","author":"ES Ford","year":"2010","unstructured":"Ford ES (2010) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 55:1310\u20131317","journal-title":"J Am Coll Cardiol"},{"key":"1548_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102\u2013110","journal-title":"Diabetes"},{"key":"1548_CR5","first-page":"567","volume":"50","author":"A Pf\u00fctzner","year":"2004","unstructured":"Pf\u00fctzner A, Kann PH, Pf\u00fctzner AH et al (2004) Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance. Clin Lab 50:567\u2013573","journal-title":"Clin Lab"},{"key":"1548_CR6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000339037","volume":"30","author":"M Li","year":"2012","unstructured":"Li M, Dou L, Jiao J et al (2012) NADPH oxidase 2-devied reactive oxygen species are involved on dysfunction and apoptosis of pancreatic \u03b2-cells induced by low density lipoprotein. Cell Physiol Biochem 30:439\u2013449","journal-title":"Cell Physiol Biochem"},{"key":"1548_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2017.24","author":"M Liang","year":"2017","unstructured":"Liang M, Li A, Lou A et al (2017) Advanced oxidation protein products promote NAPDH oxidase-dependent \u03b2-cell destruction and dysfunction through the Bcl-2\/Bax apoptotic pathway. Lab Investig. doi:\n                        10.1038\/labinvest.2017.24","journal-title":"Lab Investig"},{"key":"1548_CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.111.187310","volume":"59","author":"CS Wilcox","year":"2012","unstructured":"Wilcox CS (2012) Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension 59:375\u2013381","journal-title":"Hypertension"},{"key":"1548_CR9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1074\/jbc.M603606200","volume":"282","author":"AJ Cardounel","year":"2007","unstructured":"Cardounel AJ, Cui H, Samouilov A et al (2007) Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 282:879\u2013898","journal-title":"J Biol Chem"},{"key":"1548_CR10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1634\/stemcells.2004-0185","volume":"23","author":"O Awad","year":"2005","unstructured":"Awad O, Jiao C, Ma N, Dunnwald M, Schatteman GC (2005) Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 23:575\u2013583","journal-title":"Stem Cells"},{"key":"1548_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/CS20080263","volume":"117","author":"RM Cubbon","year":"2009","unstructured":"Cubbon RM, Kahn MB, Wheatcroft SB (2009) Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin Sci (Lond) 117:173\u2013190","journal-title":"Clin Sci (Lond)"},{"key":"1548_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jn\/116.1.36","volume":"116","author":"WJ Visek","year":"1986","unstructured":"Visek WJ (1986) Arginine needs, physiologic state and usual diets. A reevaluation. J Nutr 116:36\u201346","journal-title":"J Nutr"},{"key":"1548_CR13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nut.2004.03.021","volume":"21","author":"BJ Wells","year":"2005","unstructured":"Wells BJ, Mainous AG III, Everett CJ (2005) Association between dietary arginine and C-reactive protein. Nutrition 21:125\u2013130","journal-title":"Nutrition"},{"key":"1548_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00726-008-0210-y","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G, Bazer FW, Davis TA et al (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153\u2013168","journal-title":"Amino Acids"},{"key":"1548_CR15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1365-2362.1997.1730718.x","volume":"27","author":"TC Wascher","year":"1997","unstructured":"Wascher TC, Graier WF, Dittrich P et al (1997) Effects of low-dose l-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Investig 27:690\u2013695","journal-title":"Eur J Clin Investig"},{"key":"1548_CR16","doi-asserted-by":"crossref","first-page":"1650S","DOI":"10.1093\/jn\/137.6.1650S","volume":"137","author":"RH Boger","year":"2007","unstructured":"Boger RH (2007) The pharmacodynamics of l-arginine. J Nutr 137:1650S\u20131655S","journal-title":"J Nutr"},{"key":"1548_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/diacare.24.5.875","volume":"24","author":"PM Piatti","year":"2001","unstructured":"Piatti PM, Monti LD, Valsecchi G et al (2001) Long-term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 24:875\u2013880","journal-title":"Diabetes Care"},{"key":"1548_CR18","doi-asserted-by":"crossref","first-page":"E906","DOI":"10.1152\/ajpendo.00002.2006","volume":"291","author":"P Lucotti","year":"2006","unstructured":"Lucotti P, Setola E, Monti LD et al (2006) Beneficial effects of a long-term oral l-arginine added to a hypocaloric diet and exercise training program in obese, insulin-resistant 2 diabetic patients. Am J Physiol Endocrinol Metab 291:E906\u2013E912","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1548_CR19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.metabol.2009.03.029","volume":"58","author":"P Lucotti","year":"2009","unstructured":"Lucotti P, Monti L, Setola E et al (2009) Oral l-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aorto-coronary bypass. Metabolism 58:1270\u20131276","journal-title":"Metabolism"},{"key":"1548_CR20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1463-1326.2012.01615.x","volume":"14","author":"LD Monti","year":"2012","unstructured":"Monti LD, Setola E, Lucotti PC et al (2012) Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 14:893\u2013900","journal-title":"Diabetes Obes Metab"},{"key":"1548_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biopha.2005.05.006","volume":"59","author":"JD Mendez","year":"2005","unstructured":"Mendez JD, Hern\u00e1ndez Rde H (2005) l-Arginine and polyamine administration protect b-cells against alloxan diabetogenic effect in Sprague\u2013Dawley rats. Biomed Pharmacol 59:283\u2013289","journal-title":"Biomed Pharmacol"},{"key":"1548_CR22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1113\/jphysiol.2007.140277","volume":"584","author":"A Vasilijevic","year":"2007","unstructured":"Vasilijevic A, Buzadzic B, Korac A, Petrovic V, Jankovic A, Korac B (2007) Beneficial effects of l-arginine\u2013nitric oxide-producing pathway in rats treated with alloxan. J Physiol 584:921\u2013933","journal-title":"J Physiol"},{"key":"1548_CR23","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1210\/en.2007-1544","volume":"149","author":"XY Shi","year":"2008","unstructured":"Shi XY, Hou FF, Niu HX et al (2008) Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal adenine dinucleotide phosphate oxidase. Endocrinology 149:1829\u20131839","journal-title":"Endocrinology"},{"key":"1548_CR24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1548_CR25","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2337\/diabetes.51.7.2170","volume":"51","author":"CC Jensen","year":"2002","unstructured":"Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE, the American Diabetes Association GENNID Study Group et al (2002) Beta-cell function in a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes 51:2170\u20132178","journal-title":"Diabetes"},{"key":"1548_CR26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diabetes.54.1.166","volume":"54","author":"V Lyssenko","year":"2005","unstructured":"Lyssenko V, Almgren P, Anevski D, Botnia study group et al (2005) Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Typer 2 Diabetes. Diabetes 54:166\u2013174","journal-title":"Diabetes"},{"key":"1548_CR27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2337\/dc09-1579","volume":"33","author":"AJ Hanley","year":"2010","unstructured":"Hanley AJ, Zinman B, Sheridan P, Yusuf S, Gerstein HC, Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators (2010) Effect of rosiglitazone and ramipril on beta-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial. Diabetes Care 33:608\u2013613","journal-title":"Diabetes Care"},{"key":"1548_CR28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","volume":"348","author":"JM Hill","year":"2003","unstructured":"Hill JM, Zalos G, Halcox JP et al (2003) Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 348:593\u2013600","journal-title":"N Engl J Med"},{"key":"1548_CR29","first-page":"1","volume":"3","author":"TD Topolski","year":"2006","unstructured":"Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB (2006) The Rapid Assessment of Physical Activity (RAPA) Among Older Adults. Prev Chronic Dis 3:1","journal-title":"Prev Chronic Dis"},{"key":"1548_CR30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","volume":"20","author":"XR Pan","year":"1997","unstructured":"Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537\u2013544","journal-title":"Diabetes Care"},{"key":"1548_CR31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","volume":"355","author":"DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators","year":"2006","unstructured":"DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators (2006) Effect of ramipril on the incidence of diabetes. N Engl J Med 355:1551\u20131562","journal-title":"N Engl J Med"},{"key":"1548_CR32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstrom J, Eriksson JG, Finnish Diabetes Prevention Study Group et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343\u20131350","journal-title":"N Engl J Med"},{"key":"1548_CR33","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"WC Knowler","year":"2009","unstructured":"Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF et al (2009) 10-year Follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677\u20131686","journal-title":"Lancet"},{"key":"1548_CR34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1152\/japplphysiol.00225.2013","volume":"115","author":"L Shan","year":"2013","unstructured":"Shan L, Wang B, Gao G, Cao W, Zhang Y (2013) l-Arginine supplementation improves antioxidant defenses through l-arginine\/nitric oxide pathways in exercised rats. J Appl Physiol 115:1146\u20131155","journal-title":"J Appl Physiol"},{"key":"1548_CR35","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/mol.61.5.1081","volume":"61","author":"A Lass","year":"2002","unstructured":"Lass A, Suessnbacher A, Wolkart G, Mayer B, Brunner F (2002) Functional and analytical evidence for scavenging of oxygen radicals by l-arginine. Mol Pharmacol 61:1081\u20131088","journal-title":"Mol Pharmacol"},{"key":"1548_CR36","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1530\/JOE-13-0616","volume":"221","author":"P Newsholme","year":"2014","unstructured":"Newsholme P, Cruzat V, Arfuso F, Keane K (2014) Nutrient regulation of insulin secretion and action. J Endocrinol 221:R105\u2013R120","journal-title":"J Endocrinol"},{"key":"1548_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/JOE-11-0236","volume":"211","author":"MS Krause","year":"2011","unstructured":"Krause MS, McClenaghan NH, Flatt PR, de Bittencourt PI, Murphy C, Newsholme P (2011) l-arginine is essential for pancreatic beta-cell functional integrity, metabolism and defense from inflammatory challenge. J Endocrinol 211:87\u201397","journal-title":"J Endocrinol"},{"key":"1548_CR38","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.2337\/diab.46.12.1990","volume":"46","author":"L Mykk\u00e4nen","year":"1997","unstructured":"Mykk\u00e4nen L, Haffner SM, Hales CN, R\u00f6nnemaa T, Laakso M (1997) The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 46:1990\u20131995","journal-title":"Diabetes"},{"key":"1548_CR39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.27.6.1433","volume":"6","author":"B Zethelius","year":"2004","unstructured":"Zethelius B, Hales CN, Lithell HO, Berne C (2004) Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 6:1433\u20131438","journal-title":"Diabetes Care"},{"key":"1548_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-016-1245-6","author":"TR Araujo","year":"2016","unstructured":"Araujo TR, Freitas IN, Vettorazzi JF et al (2016) Benefits of l-alanine or l-arginine supplementation against adiposity and glucose intolerance in monosodium glutamate-induced obesity. Eur J Nutr. doi:\n                        10.1007\/s00394-016-1245-6","journal-title":"Eur J Nutr"},{"key":"1548_CR41","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","volume":"106","author":"OM Tepper","year":"2002","unstructured":"Tepper OM, Galiano RD, Capla JM et al (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781\u20132786","journal-title":"Circulation"},{"key":"1548_CR42","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","volume":"45","author":"GP Fadini","year":"2005","unstructured":"Fadini GP, Miorin M, Facco M et al (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45:1449\u20131457","journal-title":"J Am Coll Cardiol"},{"key":"1548_CR43","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1007\/s00125-007-0732-y","volume":"50","author":"GP Fadini","year":"2007","unstructured":"Fadini GP, Pucci L, Vanacore R et al (2007) Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 50:2156\u20132163","journal-title":"Diabetologia"},{"key":"1548_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1475-2840-10-113","volume":"10","author":"WS Yue","year":"2011","unstructured":"Yue WS, Lau KK, Siu CW et al (2011) Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 10:113. doi:\n                        10.1186\/1475-2840-10-113","journal-title":"Cardiovasc Diabetol"},{"key":"1548_CR45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2217\/17520363.2.4.317","volume":"2","author":"G Schernthaner","year":"2008","unstructured":"Schernthaner G, Krzyzanowska K (2008) Role of asymmetric dimethylarginine in cardiovascular disease and diabetes. Biomarkers Med 2:317\u2013320","journal-title":"Biomarkers Med"},{"key":"1548_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1475-2840-12-64","volume":"12","author":"A Surdacki","year":"2013","unstructured":"Surdacki A, Kruszelnicka O, Rakowski T, Ja\u017awi\u0144ska-Kozuba A, Dubiel JS (2013) Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study. Cardiovasc Diabetol 12:64. doi:\n                        10.1186\/1475-2840-12-64","journal-title":"Cardiovasc Diabetol"},{"key":"1548_CR47","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","volume":"290","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2003","unstructured":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159\u20132167","journal-title":"JAMA"},{"key":"1548_CR48","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMe0807625","volume":"359","author":"J Chalmers","year":"2008","unstructured":"Chalmers J, Cooper ME (2008) UKPDS and the legacy effect. N Engl J Med 359:1618\u20131620","journal-title":"N Engl J Med"},{"key":"1548_CR49","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"issue":"suppl 8S","key":"1548_CR50","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0002-8223(99)00416-2","volume":"99","author":"ML McCullough","year":"1999","unstructured":"McCullough ML, Karanja NM, Lin PH et al (1999) Comparison of 4 nutrient databases with chemical composition data from the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc 99(suppl 8S):S45\u2013S53","journal-title":"J Am Diet Assoc"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-017-1548-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-017-1548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-017-1548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T16:32:50Z","timestamp":1542731570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-017-1548-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1007\/s00394-017-1548-2","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,20]]}}}